plant lover, cookie monster, shoe fiend
19653 stories
·
21 followers

EU pauses trade retaliation against US after Trump’s 30% tariff threat

1 Comment
JavaScript is disabled in your browser.

Please enable JavaScript to proceed.

Read the whole story
sarcozona
3 hours ago
reply
Russia is handling near global sanctions better than the EU is handling US tariff threats
Epiphyte City
Share this story
Delete

Jan Wildeboer 😷:krulorange

1 Comment
Read the whole story
sarcozona
7 hours ago
reply
This is about the largest car that should be street legal. Then we really could share the road.
Epiphyte City
Share this story
Delete

Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters | Journal of Translational Medicine

1 Share
  1. Zhou P, Yang XLL, Wang XGG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184:861–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Sette A, Sidney J, Crotty S. T cell responses to SARS-CoV-2. Annu Rev Immunol. 2023;41:343–73.

    CAS  PubMed  Google Scholar 

  4. Goldblatt D, Alter G, Crotty S, Plotkin SA. Correlates of protection against SARS-CoV-2 infection and COVID-19 disease. Immunol Rev. 2022. https://doi.org/10.1111/imr.13091.

    PubMed  PubMed Central  Google Scholar 

  5. Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27:1205–11.

    CAS  PubMed  Google Scholar 

  6. Earle KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, Gilbert PB, Siber GR, et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine Elsevier. 2021;39:4423–8.

    CAS  Google Scholar 

  7. Sun Y, Huang W, Xiang H, Nie J. SARS-CoV-2 neutralization assays used in clinical trials: a narrative review. Vaccines. 2024;12:554.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Israel A, Shenhar Y, Green I, Merzon E, Golan-Cohen A, Schäffer AA, et al. Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection. Vaccines. 2021;10:64.

    PubMed  PubMed Central  Google Scholar 

  9. Pradenas E, Marfil S, Urrea V, Trigueros M, Pidkova T, Pons-Grífols A, et al. Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization. iScience. 2023;26: 106457.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Rodda LB, Morawski PA, Pruner KB, Fahning ML, Howard CA, Franko N, et al. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity. Cell. 2022;185:1588-1601.e14.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Jones JM, Manrique IM, Stone MS, Grebe E, Saa P, Germanio CD, et al. Estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status—United States, April 2021–September 2022. MMWR Morb Mortal Wkly Rep. 2023;72:601–5.

    PubMed  PubMed Central  Google Scholar 

  12. Pather S, Madhi SA, Cowling BJ, Moss P, Kamil JP, Ciesek S, et al. SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines. Front Immunol. 2023;14:1130539.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Andrews N, Tessier E, Stowe J, Gower C, Kirsebom F, Simmons R, et al. Duration of protection against mild and severe disease by Covid-19 vaccines. N Engl J Med. 2022;386:340–50.

    CAS  PubMed  Google Scholar 

  14. Wang L, Nicols A, Turtle L, Richter A, Duncan CJ, Dunachie SJ, et al. T cell immune memory after covid-19 and vaccination. BMJ Med. 2023;2: e000468.

    PubMed  PubMed Central  Google Scholar 

  15. Srivastava K, Carreño JM, Gleason C, Monahan B, Singh G, Abbad A, et al. SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase. Immunity. 2024;57:587-599.e4.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Pegu A, O’Connell SE, Schmidt SD, O’Dell S, Talana CA, Lai L, et al. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science. 2021;373:1372–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Saiag E, Alcalay Y, Marudi O, Orr-Urtreger A, Hagin D. Cellular and humoral immune response to the fourth Pfizer-BioNTech COVID-19 vaccine dose in individuals aged 60 years and older. Vaccine Elsevier. 2023;41:914–21.

    CAS  Google Scholar 

  18. Gilboa M, Regev-Yochay G, Mandelboim M, Indenbaum V, Asraf K, Fluss R, et al. Durability of immune response after COVID-19 booster vaccination and association with COVID-19 omicron infection. JAMA Netw open. 2022;5: e2231778.

    PubMed  PubMed Central  Google Scholar 

  19. Trinité B, Tarrés-Freixas F, Rodon J, Pradenas E, Urrea V, Marfil SS, et al. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity. Sci Rep. 2021;11:2608.

    PubMed  PubMed Central  Google Scholar 

  20. Pradenas E, Trinité B, Urrea V, Marfil S, Ávila-Nieto C, Rodríguez de la Concepción ML, et al. Stable neutralizing antibody levels 6 months after mild and severe COVID-19 episodes. Med. 2021;2:313-320.e4.

    CAS  PubMed  Google Scholar 

  21. Pradenas E, Trinité B, Urrea V, Marfil S, Tarrés-Freixas F, Ortiz R, et al. Clinical course impacts early kinetics, magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection. Cell Rep Med. 2022;3: 100523.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Marshall JC, Murthy S, Diaz J, Adhikari N, Angus DC, Arabi YM, et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192–7.

    CAS  Google Scholar 

  23. Ministerio de Sanidad-Estrategia de vacunación COVID-19 en España.

  24. Spikevax: EMA recommendation on booster|European Medicines Agency (EMA).

  25. Connor RI, Chen BK, Choe S, Landau NR. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995;206:935–44.

    CAS  PubMed  Google Scholar 

  26. Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11:1–12.

    Google Scholar 

  27. Sánchez-Palomino S, Massanella M, Carrillo J, García A, García F, González N, et al. A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity. Vaccine. 2011;29:5250–9.

    PubMed  Google Scholar 

  28. Li X, Zhong X, Wang Y, Zeng X, Luo T, Liu Q. Clinical determinants of the severity of COVID-19: a systematic review and meta-analysis. PLoS ONE. 2021;16: e0250602.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Beaudoin-Bussières G, Finzi A. Deciphering Fc-effector functions against SARS-CoV-2. Trends Microbiol. 2024;32:756–68.

    PubMed  Google Scholar 

  30. Cao YL, Jian FC, Wang J, Yu YL, Song WL, Yisimayi A, et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature. 2023;614:521.

    CAS  PubMed  Google Scholar 

  31. Meijers M, Ruchnewitz D, Eberhardt J, Łuksza M, Lässig M. Population immunity predicts evolutionary trajectories of SARS-CoV-2. Cell. 2023;186:5151–64.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, et al. Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial. Nat Commun. 2024;15:9785.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Favresse J, Gillot C, Bayart J, David C, Simon G, Wauthier L, et al. Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster. J Med Virol. 2023;95: e28164.

    CAS  PubMed  Google Scholar 

  34. Arunachalam PS, Lai L, Samaha H, Feng Y, Hu M, Hui HS, et al. Durability of immune responses to mRNA booster vaccination against COVID-19. J Clin Invest. 2023;133: e167955.

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Lumley SF, Wei J, O’Donnell D, Stoesser NE, Matthews PC, Howarth A, et al. The duration, dynamics, and determinants of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) antibody responses in individual healthcare workers. Clin Infect Dis. 2021;73:E699-709.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Tong X, Kellman B, Avendano M-J, Mendu M, Hsiao JC, Serrano E, et al. Humoral waning kinetics against SARS-CoV-2 is dictated by disease severity and vaccine platform. medRxiv. 2024;2024.10.17.24315607.

  37. Aldridge RW, Yavlinsky A, Nguyen V, Eyre MT, Shrotri M, Navaratnam AMD, et al. SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort. Nat Commun. 2022;13:4869.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Mix E, Goertsches R, Zett UK. Immunoglobulins—basic considerations. J Neurol. 2006;253:v9-17.

    PubMed  Google Scholar 

  39. Mankarious S, Lee M, Fischer S, Pyun KH, Ochs HD, Oxelius VA, et al. The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin. J Lab Clin Med. 1988;112:634–40.

    CAS  PubMed  Google Scholar 

  40. Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, Schmitz AJ, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421–5.

    CAS  PubMed  Google Scholar 

  41. Nguyen DC, Hentenaar IT, Morrison-Porter A, Solano D, Haddad NS, Castrillon C, et al. SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccination. Nat Med. 2024;31:235–44.

    PubMed  PubMed Central  Google Scholar 

  42. Tolan NV, Sherman AC, Zhou G, Nabel KG, Desjardins M, Melanson S, et al. The effect of vaccine type and SARS-CoV-2 lineage on commercial SARS-CoV-2 serologic and pseudotype neutralization assays in mRNA vaccine recipients. Microbiol Spectr. 2022;10: e00211-22.

    PubMed  PubMed Central  Google Scholar 

  43. Steensels D, Pierlet N, Penders J, Mesotten D, Heylen L. Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273. JAMA. 2021;326:1533–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, et al. Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. 2020;21:1506–16.

    PubMed  PubMed Central  Google Scholar 

  45. Rubio R, Macià D, Barrios D, Vidal M, Jiménez A, Molinos-Albert LM, et al. High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination. Microbes Infect. 2024;27: 105423.

    PubMed  Google Scholar 

  46. Trinité B, Pradenas E, Marfil S, Rovirosa C, Urrea V, Tarrés-Freixas F, et al. Previous SARS-CoV-2 infection increases B117 cross-neutralization by vaccinated individuals. Viruses. 2021;13:1135.

    PubMed  PubMed Central  Google Scholar 


Page 2

Group

Parameter

Estimated value

95% confidence interval

p-valuea

Infected mild

Half-life (days)

19

10–102

0.017

Peak (log10)

2.99

2.75–3.23

< 0.0001

Plateau (log10)

2.51

2.45–2.58

< 0.0001

Infected hosp.

Half-life (days)

29

22–41

< 0.0001

Peak (log10)

3.83

3.67–3.98

< 0.0001

Plateau (log10)

2.94

2.85–3.03

< 0.0001

Uninfected vac

Half-life (days)

39

31–51

< 0.0001

Peak (log10)

3.75

3.64–3.86

< 0.0001

Plateau (log10)

2.61

2.48–2.74

< 0.0001

Infected vac

Half-life (days)

60

48–78

< 0.0001

Peak (log10)

3.94

3.86–4.02

< 0.0001

Plateau (log10)

3.04

2.93–3.15

< 0.0001

Uninfected boosted

Half-life (days)

60

35197

0.0055

Peak (log10)

3.69

3.513.87

< 0.0001

Plateau (log10)

2.85

2.543.17

< 0.0001

Infected boosted

Half-life (days)

49

3774

< 0.0001

Peak (log10)

3.84

3.723.96

< 0.0001

Plateau (log10)

2.97

2.853.10

< 0.0001

BTI

Half-life (days)

71

50125

< 0.0001

Peak (log10)

3.68

3.543.82

< 0.0001

Plateau (log10)

2.68

2.343.03

< 0.0001

All boosted

Half-life (days)

57

45–76

< 0.0001

Peak (log10)

3.76

3.68–3.84

< 0.0001

Plateau (log10)

2.89

2.77–3.00

< 0.0001

  1. aestimated p-value (Wald test) indicates difference from zero (not comparison among groups). Half-life p-values correspond to the decay constant (ka) estimates. The main groups analyzed are highlighted in bold. All Boosted group includes Boosted and BTI subgroups
Read the whole story
sarcozona
7 hours ago
reply
Epiphyte City
Share this story
Delete

Her Year Without Touch

1 Comment

Sex worker Isabelle Fox talks in this video (backup link) about the year she went without sex and how the truly remarkable thing for her wasn’t missing the sex as such but rather the realization that she simply missed physical touch:

I went 12 months without sex, which was a record for me because I’d been a professional for six years. But I went through something really heavy in my personal life and it made interactions with men feel almost impossible.

But what it did do was for the first time I truly understood why so many of my clients used to come and see me. While I did eventually miss the sex, that is not what hit me first around month nine. What I really missed was physical intimacy, like just the feeling of another person’s skin, completely non-sexual.

I was a hermit alone in my apartment for basically that entire time. And the most physical contact I got was in the infrequent sessions I have with the personal trainer where they measure my body.

Now babies who don’t get touch die from lack of it. That’s how essential it is. Then around month 10, I started missing the smell of men. And this was sexual. I was in a gym in New York and this guy was near me and I just thought, oh, that smells good. And from that moment, I started noticing men again. And over the next two months, that feeling just kept growing until it became undeniable and I finally acted on it with a man.

It was enjoyable and honestly incredibly cathartic. Up until then, my compassion for my clients had been mostly intellectual. Like I got intellectually what they were dealing with because they told me about it, but I’ve never really been through it to understand. I had always been in relationships even throughout my entire time as a sex worker. I’d never experienced a total lack of emotional or physical intimacy. And wow, it was hard. We really are made for intimacy.

Meanwhile I’m having a parallel reaction to her “discovery”, as I suspect many other men will too. What’s a revelation to her, is just the normal experience of life for a great many men, as she acknowledges when she talks about hearing about it from her clients. Indeed, the trick might be finding a man who hasn’t had the experience while he’s actually living with a woman he’s committed to.


View this post in its original location at ErosBlog: The Sex Blog.
If you are reading this anywhere but in a feed reader, it has been scraped without permission. Feed obtained by: (173.230.155.197)

Similar Sex Blogging:

The post Her Year Without Touch appeared first on ErosBlog.

Read the whole story
sarcozona
23 hours ago
reply
Touch starvation is real hard. Men need to learn to touch each other.
Epiphyte City
Share this story
Delete

Iron Spike ‪@ironspike.bsky.social‬

1 Comment and 2 Shares

100%: Zeboyd Digital Entertainment ‪@zeboydgames.bsky.social‬

If "AI" was as valuable as they say it is, they wouldn't be selling it to you. They'd be using it themselves in secret to make the next Minecraft, the next Avatar, the next Hello Kitty and then they'd sell that to you.

They're trying to sell you a sick goose, while pretending it lays golden eggs.

Which Iron Spike ‪@ironspike.bsky.social‬ quote posted with:

This is put so well.

There are absolutely parallels with cryptobros screaming at you about the impending death of fiat currency.

"Hyperinflation! Great Depression 2.0! Government collapse!!! Your stupid paper money will be worthless, soon! SOOOON!

...

Best to just give it all to me now!"

‪Zeboyd Digital Entertainment‬

Read the whole story
sarcozona
23 hours ago
reply
Omg so acting like chat gpt customer service is the whole field. AI is literally being used for all kinds of useful and real things constantly - robots using AI just moved an entire city block in Shanghai
Epiphyte City
rocketo
21 hours ago
reply
seattle, wa
Share this story
Delete

Billionaire math

1 Comment and 2 Shares

I have a friend who exited his startup a few years ago and is now rich. How rich is unclear. One day, we were discussing ways to expedite the delivery of his superyacht and I suggested paying extra. His response, as to so many of my suggestions, was, “Avery, I’m not that rich.”

Everyone has their limit.

I, too, am not that rich. I have shares in a startup that has not exited, and they seem to be gracefully ticking up in value as the years pass. But I have to come to work each day, and if I make a few wrong medium-quality choices (not even bad ones!), it could all be vaporized in an instant. Meanwhile, I can’t spend it. So what I have is my accumulated savings from a long career of writing software and modest tastes (I like hot dogs).

Those accumulated savings and modest tastes are enough to retire indefinitely. Is that bragging? It was true even before I started my startup. Back in 2018, I calculated my “personal runway” to see how long I could last if I started a company and we didn’t get funded, before I had to go back to work. My conclusion was I should move from New York City back to Montreal and then stop worrying about it forever.

Of course, being in that position means I’m lucky and special. But I’m not that lucky and special. My numbers aren’t that different from the average Canadian or (especially) American software developer nowadays. We all talk a lot about how the “top 1%” are screwing up society, but software developers nowadays fall mostly in the top 1-2%[1] of income earners in the US or Canada. It doesn’t feel like we’re that rich, because we’re surrounded by people who are about equally rich. And we occasionally bump into a few who are much more rich, who in turn surround themselves with people who are about equally rich, so they don’t feel that rich either.

But, we’re rich.

Based on my readership demographics, if you’re reading this, you’re probably a software developer. Do you feel rich?

It’s all your fault

So let’s trace this through. By the numbers, you’re probably a software developer. So you’re probably in the top 1-2% of wage earners in your country, and even better globally. So you’re one of those 1%ers ruining society.

I’m not the first person to notice this. When I read other posts about it, they usually stop at this point and say, ha ha. Okay, obviously that’s not what we meant. Most 1%ers are nice people who pay their taxes. Actually it’s the top 0.1% screwing up society!

No.

I’m not letting us off that easily. Okay, the 0.1%ers are probably worse (with apologies to my friend and his chronically delayed superyacht). But, there aren’t that many of them[2] which means they aren’t as powerful as they think. No one person has very much capacity to do bad things. They only have the capacity to pay other people to do bad things.

Some people have no choice but to take that money and do some bad things so they can feed their families or whatever. But that’s not you. That’s not us. We’re rich. If we do bad things, that’s entirely on us, no matter who’s paying our bills.

What does the top 1% spend their money on?

Mostly real estate, food, and junk. If they have kids, maybe they spend a few hundred $k on overpriced university education (which in sensible countries is free or cheap).

What they don’t spend their money on is making the world a better place. Because they are convinced they are not that rich and the world’s problems are caused by somebody else.

When I worked at a megacorp, I spoke to highly paid software engineers who were torn up about their declined promotion to L4 or L5 or L6, because they needed to earn more money, because without more money they wouldn’t be able to afford the mortgage payments on an overpriced $1M+ run-down Bay Area townhome which is a prerequisite to starting a family and thus living a meaningful life. This treadmill started the day after graduation.[3]

I tried to tell some of these L3 and L4 engineers that they were already in the top 5%, probably top 2% of wage earners, and their earning potential was only going up. They didn’t believe me until I showed them the arithmetic and the economic stats. And even then, facts didn’t help, because it didn’t make their fears about money go away. They needed more money before they could feel safe, and in the meantime, they had no disposable income. Sort of. Well, for the sort of definition of disposable income that rich people use.[4]

Anyway there are psychology studies about this phenomenon. “What people consider rich is about three times what they currently make.” No matter what they make. So, I’ll forgive you for falling into this trap. I’ll even forgive me for falling into this trap.

But it’s time to fall out of it.

The meaning of life

My rich friend is a fountain of wisdom. Part of this wisdom came from the shock effect of going from normal-software-developer rich to founder-successful-exit rich, all at once. He described his existential crisis: “Maybe you do find something you want to spend your money on. But, I'd bet you never will. It’s a rare problem. Money, which is the driver for everyone, is no longer a thing in my life.

Growing up, I really liked the saying, “Money is just a way of keeping score.” I think that metaphor goes deeper than most people give it credit for. Remember old Super Mario Brothers, which had a vestigial score counter? Do you know anybody who rated their Super Mario Brothers performance based on the score? I don’t. I’m sure those people exist. They probably have Twitch channels and are probably competitive to the point of being annoying. Most normal people get some other enjoyment out of Mario that is not from the score. Eventually, Nintendo stopped including a score system in Mario games altogether. Most people have never noticed. The games are still fun.

Back in the world of capitalism, we’re still keeping score, and we’re still weirdly competitive about it. We programmers, we 1%ers, are in the top percentile of capitalism high scores in the entire world - that’s the literal definition - but we keep fighting with each other to get closer to top place. Why?

Because we forgot there’s anything else. Because someone convinced us that the score even matters.

The saying isn’t, “Money is the way of keeping score.” Money is just one way of keeping score.

It’s mostly a pretty good way. Capitalism, for all its flaws, mostly aligns incentives so we’re motivated to work together and produce more stuff, and more valuable stuff, than otherwise. Then it automatically gives more power to people who empirically[5] seem to be good at organizing others to make money. Rinse and repeat. Number goes up.

But there are limits. And in the ever-accelerating feedback loop of modern capitalism, more people reach those limits faster than ever. They might realize, like my friend, that money is no longer a thing in their life. You might realize that. We might.

There’s nothing more dangerous than a powerful person with nothing to prove

Billionaires run into this existential crisis, that they obviously have to have something to live for, and money just isn’t it. Once you can buy anything you want, you quickly realize that what you want was not very expensive all along. And then what?

Some people, the less dangerous ones, retire to their superyacht (if it ever finally gets delivered, come on already). The dangerous ones pick ever loftier goals (colonize Mars) and then bet everything on it. Everything. Their time, their reputation, their relationships, their fortune, their companies, their morals, everything they’ve ever built. Because if there’s nothing on the line, there’s no reason to wake up in the morning. And they really need to want to wake up in the morning. Even if the reason to wake up is to deal with today’s unnecessary emergency. As long as, you know, the emergency requires them to do something.

Dear reader, statistically speaking, you are not a billionaire. But you have this problem.

So what then

Good question. We live at a moment in history when society is richer and more productive than it has ever been, with opportunities for even more of us to become even more rich and productive even more quickly than ever. And yet, we live in existential fear: the fear that nothing we do matters.[6][7]

I have bad news for you. This blog post is not going to solve that.

I have worse news. 98% of society gets to wake up each day and go to work because they have no choice, so at worst, for them this is a background philosophical question, like the trolley problem.

Not you.

For you this unsolved philosophy problem is urgent right now. There are people tied to the tracks. You’re driving the metaphorical trolley. Maybe nobody told you you’re driving the trolley. Maybe they lied to you and said someone else is driving. Maybe you have no idea there are people on the tracks. Maybe you do know, but you’ll get promoted to L6 if you pull the right lever. Maybe you’re blind. Maybe you’re asleep. Maybe there are no people on the tracks after all and you’re just destined to go around and around in circles, forever.

But whatever happens next: you chose it.

We chose it.

Footnotes

[1] Beware of estimates of the “average income of the top 1%.” That average includes all the richest people in the world. You only need to earn the very bottom of the 1% bucket in order to be in the top 1%.

[2] If the population of the US is 340 million, there are actually 340,000 people in the top 0.1%.

[3] I’m Canadian so I’m disconnected from this phenomenon, but if TV and movies are to be believed, in America the treadmill starts all the way back in high school where you stress over getting into an elite university so that you can land the megacorp job after graduation so that you can stress about getting promoted. If that’s so, I send my sympathies. That’s not how it was where I grew up.

[4] Rich people like us methodically put money into savings accounts, investments, life insurance, home equity, and so on, and only what’s left counts as “disposable income.” This is not the definition normal people use.

[5] Such an interesting double entendre.

[6] This is what AI doomerism is about. A few people have worked themselves into a terror that if AI becomes too smart, it will realize that humans are not actually that useful, and eliminate us in the name of efficiency. That’s not a story about AI. It’s a story about what we already worry is true.

[7] I’m in favour of Universal Basic Income (UBI), but it has a big problem: it reduces your need to wake up in the morning. If the alternative is bullshit jobs or suffering then yeah, UBI is obviously better. And the people who think that if you don’t work hard, you don’t deserve to live, are nuts. But it’s horribly dystopian to imagine a society where lots of people wake up and have nothing that motivates them. The utopian version is to wake up and be able to spend all your time doing what gives your life meaning. Alas, so far science has produced no evidence that anything gives your life meaning.

Read the whole story
sarcozona
1 day ago
reply
I think part of this has to do with housing prices (in both countries) and medical expenses (in the US especially). If safe, comfortable housing in a place you don’t hate living is unaffordable, how are you rich? If you got cancer or a car paralyzed you tomorrow and the medical and caretaking expenses would bankrupt you years before you died, are you actually rich?

He talks about safety here like people are delusional, but they’re actually being reasonable. More reasonable would be to do Vienna style public housing everywhere and socialize medical care and actually take care of disabled people.
Epiphyte City
Share this story
Delete
Next Page of Stories